Shed vs SkinnyRx: coaching and injections vs oral semaglutide options
Shed vs SkinnyRx compares two different approaches to GLP-1 care: Shed pairs name-brand and compounded injectable options with continuous coaching and a 2-minute approval assessment, starting at $199/month, while SkinnyRx offers daily oral semaglutide tablets with FSA/HSA eligibility and free overnight shipping as low as $249/mo. Verdict early on: choose Shed if you want integrated coaching and both name-brand and compounded injections; choose SkinnyRx if you prefer oral tablets with fast shipping and FSA/HSA flexibility.
Start Shed 2-minute assessment
Shed vs SkinnyRx at a glance
This direct comparison focuses on the most distinctive differences supported by the source: medication format and options, coaching and support, pricing entry points and discounts, delivery and financial tools, and regulatory notes about compounded drugs. Each point compares Shed and SkinnyRx directly using only supplied facts.
Comparison table
| Criteria | Shed | SkinnyRx |
|---|---|---|
| Medication format | Name-brand and compounded GLP-1 injections, microdose options | Daily compounded semaglutide tablets taken under the tongue |
| Coaching and support | Continuous coaching integrated into treatment | Personalized care and ongoing support from providers |
| Starting price / offer | Compounded semaglutide starting at $199/month; 10% off your first month | As low as $249/mo; free overnight shipping |
| Financial tools and shipping | 10% off first month noted as a limited time offer | FSA/HSA eligible and free overnight shipping; split payments with Affirm |
| Regulatory note | Compounded medications are not FDA-approved and not reviewed by FDA | Compounded medications are not FDA-approved and not reviewed by FDA |
1. Medication format and choice
Shed offers both FDA-approved name-brand GLP-1 and compounded options on one platform, including compounded semaglutide and tirzepatide injections and microdose GLP-1. This gives patients flexibility to choose name-brand medications with regulatory assurance or compounded alternatives that can be more affordable. SkinnyRx focuses on daily compounded semaglutide tablets taken under the tongue, providing an oral alternative to injections. If you need injectable name-brand options, the source supports Shed. If you prefer oral dosing, the source supports SkinnyRx.
Explore SkinnyRx oral semaglutide
2. Coaching, monitoring, and patient support
Both platforms offer clinician review before prescribing, but Shed emphasizes continuous coaching integrated into the treatment plan rather than just issuing a prescription. The source explicitly positions Shed for patients who want behavioral support alongside medication. SkinnyRx also provides personalized care and ongoing provider support and monitors progress to adjust doses as needed. The difference is stated as Shed bundling continuous coaching into treatment, while SkinnyRx highlights clinician-guided adjustments and unlimited access to patient care teams.
Get Shed coaching plus medication
3. Pricing, discounts, and financial tools
Price entry points differ in the supplied facts. Shed lists compounded semaglutide injections starting at $199/month and compounded tirzepatide starting at $299/month and advertises 10% off your first month as a limited time offer. SkinnyRx lists oral semaglutide as low as $249/mo, notes FSA/HSA eligibility so you can use pre-tax dollars, and offers free overnight shipping and payment splitting with Affirm. The source does not publish standard pricing for some name-brand options on Shed; Shed provides personalized quotes after intake.
4. Delivery timing and logistics
SkinnyRx advertises free overnight shipping and that after a prescription is written you receive shipping and tracking information within 2 business days. Shed notes medication is shipped after clinician approval and includes coaching from the start, but the source does not provide a specific shipping speed. Both require a clinician review and an online consultation before a prescription is issued.
5. Regulatory and safety notes
Both sources include the regulatory caution that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality. Shed explicitly repeats this and clarifies that a prescription is issued only after a licensed clinician determines treatment is appropriate. SkinnyRx notes partner pharmacies perform third-party testing for quality control every 3 to 6 months and states compounded semaglutide has not been approved by the FDA for weight loss. Results may vary for both providers.
Conclusion: Which should you choose in the Shed vs SkinnyRx comparison
In short, Shed is best for patients who want both name-brand and compounded injectable GLP-1 options with integrated, continuous coaching and a fast 2-minute assessment, starting at $199/month for compounded semaglutide and including a 10% off limited time offer for the first month. SkinnyRx is best for people who prefer an oral semaglutide tablet, value FSA/HSA eligibility and free overnight shipping, and want the convenience of as low as $249/mo plans and clinician-guided dose adjustments.
Start Shed intake for name-brand or compounded options
Start SkinnyRx consultation for oral tablets
Choose Shed if you want integrated coaching, a 2-minute approval assessment, and access to both name-brand and compounded injectable GLP-1 options starting at $199/month. Choose SkinnyRx if you prefer daily oral semaglutide tablets with FSA/HSA eligibility, free overnight shipping, and plans as low as $249/mo. In the Shed vs SkinnyRx comparison, select the platform whose medication format and financial tools match your needs.